Capricor Therapeutics Inc.
CAPR | NASDAQ
$9.23
+$0.33 (+3.71%)
Sep 22, 2026, 10:36 AM ET · Market open
Market Data
Market Cap $511.84M
Enterprise Value $-146.38B
Beta 0.53
Average Volume 4.63M
Shares Outstanding (Diluted) 57.93M
Shares Change YoY 26.73%
Institutional Ownership 58.90%
Exchange NASDAQ
ISIN US14070B3096
Price Performance
Price Change 1M 11.0%
Price Change 3M -69.9%
Price Change 6M -70.2%
Price Change YTD -68.6%
Price Change 1Y 46.1%
Price Change 3Y 61.8%
Price Change 5Y 70.2%
1M CAGR (ann.) 117.6%
1Y CAGR (ann.) 39.1%
5Y CAGR (ann.) 13.3%
All-Time CAGR -18.1%
Valuation
PE Ratio -3.63
Forward PE 33.15
PEG Ratio 0.09
Forward PEG 1.10
PS Ratio N/A
Forward PS 6.10
PB Ratio 0.00
P/FCF Ratio -5.54
P/Adj. FCF Ratio -0.04
P/OCF Ratio -4.94
EV/Sales N/A
EV/EBIT 1,138.39
EV/EBITDA 3.48
EV/FCF 1,584.32
Earnings Yield -27.5%
FCF Yield -18.1%
Adj. FCF Yield -2666.0%
Financial Health
Net Cash $146.89B
Total Debt $91.05B
Cash & Short-Term Investments $237.93B
Total Assets $368.74B
Current Ratio 7.35
Quick Ratio 7.35
Debt / Equity Ratio 0.37
Debt / EBITDA -2.17
Debt / FCF -985.43
OCF / Debt -0.00
Interest Coverage -44.38
Altman Z-Score -1.44
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -14669.4%
Returns
Return on Assets -35.1%
Return on Equity -56.6%
Return on Invested Capital -40.1%
Return on Capital Employed -40.3%
Return on Tangible Assets -35.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -100.5%
Revenue CAGR 5Y 3.9%
Revenue CAGR 10Y 22.5%
EPS CAGR 3Y -45.4%
EPS CAGR 5Y -22.8%
EPS CAGR 10Y 15.5%
FCF CAGR 3Y -45.7%
FCF CAGR 5Y -58.7%
FCF CAGR 10Y -14.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 32.9%
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.14
EPS Growth Est (next Q) -74.5%
Revenue Est (next Q) $41.71M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12.70
Price Target Upside 42.7%
Cash Flow
Operating Cash Flow $-72.51M
Free Cash Flow $-92.39M
Adj. Free Cash Flow $-13.65B
FCF Per Share -$2.24
OCF Per Share -$1.80
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-20.36M
Operating Income $-135.16M
EBITDA $-42.03B
Net Income $-40.82B
EPS (Diluted) -$2.45
Revenue / Employee N/A
Profit / Employee $-176.72M
Employees 231
Add to Watchlist
Select watchlists to add or remove CAPR